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Abstract In the present study, we assessed the strongest
determinants of plasma coenzyme Q10 (Q10) in 518 men and
women (aged 45^70 years) with a stepwise multivariate
regression model. Male gender (P6 0.001), serum cholesterol
(P6 0.001), serum Q-glutamyltransferase (P6 0.001), serum
triglycerides (P6 0.001), age (P = 0.017) and 4-day alcohol
consumption (P = 0.03) were the most important factors which
were directly associated with plasma Q10. The intensity of
conditioning exercise (P = 0.03) and use of statins (P6 0.05)
showed an inverse association with plasma Q10. None of the
assessed nutrients increased plasma Q10 levels significantly. Our
results suggest that many confounding factors, in addition to
serum cholesterol and triglycerides, should be taken into account
when the role of plasma Q10 is examined in epidemiological
research.
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1. Introduction
Several chromatographic measurement methods for plasma
coenzyme Q10 (Q10) have been published recently [1^3]. How-
ever, there are no previous population studies assessing either
endogenous or exogenous (dietary) determinants of plasma
coenzyme Q10 concentration in humans. This is a serious
shortcoming, because measurement of plasma Q10 has been
claimed to be of clinical signi¢cance [4^6]. Lack of this infor-
mation can, however, lead to incorrect conclusions.
The range for plasma Q10 concentration in humans is typ-
ically 0.5^2 Wmol/l [7]. It is already well established that plas-
ma Q10 concentration is highly dependent on serum lipopro-
teins (cholesterol levels), which are the carriers of Q10 in the
circulation [8,9]. Furthermore, there is a preliminary ¢nding
that the plasma coenzyme Q10 levels are higher in men than in
women (n = 10) [10]. However, these ¢ndings have not been
con¢rmed in population studies. In addition to endogenous
factors, the diet can in£uence the plasma Q10 concentration,
due to the long half-life of this coenzyme in the circulation
[11]. In humans, the major dietary sources of Q10 are consid-
ered to be meat, ¢sh and some vegetables [12,13].
If one is to use plasma Q10 levels reliably for clinical pur-
poses, it is crucial to know which di¡erent exogenous and
endogenous factors can in£uence their levels. The aim of
this study was to identify the major determinants of plasma
total Q10 in middle-aged and older men and postmenopausal
women.
2. Materials and methods
2.1. Study population
The present study examined 45^70-year-old smoking (s 5 ciga-
rettes/day) and non-smoking men (n = 254) and postmenopausal wom-
en (n = 264) taking part in the ASAP (Antioxidant Supplementation in
Atherosclerosis Prevention) study. All subjects had a mild hypercho-
lesterolemia, de¢ned as serum cholesterol of at least 5.0 mmol/l at a
screening visit. Twelve subjects were taking a regular HMG-CoA
reductase inhibitor (statin) treatment. All subjects provided written
informed consent. The study protocol was approved by the Research
Ethics Committee of the University of Kuopio. Subjects were in-
structed to abstain from eating for 12 h and from ingesting alcohol
for a week before blood sampling.
Exclusion criteria were premenopause or regular oral estrogen
substitution therapy, regular intake of antioxidants, acetylsalicylic
acid or any other drug with established antioxidative properties, se-
vere obesity (body mass index s 32 kg/m2), insulin-dependent (type 1)
diabetes, uncontrolled hypertension (sitting diastolic blood pressure
s 105 mm Hg) at a screening visit or any condition that would limit
the mobility of the subject making study visits impossible.
2.2. Food recordings and questionnaires
The consumption of foods (including 4-day alcohol consumption)
was assessed at the time of blood sampling by asking the subject to
bring a 4-day food record weighed with household measures [14],
which was checked by a nutritionist. The intake of nutrients was
estimated using NUTRICA software based on mainly Finnish values
for the nutrient composition of foods.
Intensity of conditioning activity, smoking, use of statins and mean
weekly alcohol consumption (based on 12-month use) were assessed
by a separate questionnaire. Weight and height for body mass index
(BMI) were assessed by a nurse.
2.3. Chemical measurements
Plasma total Q10 levels were measured chromatographically with an
electrochemical method [15]. Serum cholesterol (Kone Instruments,
Espoo, Finland) and serum triglycerides (Boehringer Mannheim,
Mannheim, Germany) were measured enzymatically. Serum Q-gluta-
myltransferase (Q-GT) activity was measured with a standardized
method [16].
2.4. Statistical analysis
A number of possible determinants of plasma Q10 concentration,
including age, physical activity, cigarette smoking, alcohol consump-
tion, dietary intake of nutrients, medication (statins), BMI, diseases,
such as history of diabetes, cancer, hypertension and atherosclerosis,
biochemical factors, such as serum lipids, serum albumin (the major
thiol in plasma), serum Q-GT, serum carbohydrate-de¢cient transferrin
(CDT), hemoglobin, leukocytes and whole blood glutathione (as an
endogenous antioxidant) were included in a step-up linear multivari-
ate regression model (P = 0.2 for entry). Dietary antioxidants were not
included in the statistical analysis because of their dependence on
nutrients. In addition, variance analysis and covariance analysis (AN-
COVA) were used to test di¡erences in plasma Q10 levels both be-
tween men and women and between users and non-users of statins.
Variance analysis was also used to test linearity across groups (P for
trend).
3. Results
The means, standard deviations and ranges of determinants
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of plasma Q10 are presented in Table 1. A stepwise multivari-
ate regression model was used to study the strongest determi-
nants of plasma total Q10 concentration. Of the tested varia-
bles, serum cholesterol, serum Q-GT, male gender, serum
triglycerides, 4-day alcohol consumption, age, BMI, smoking,
intake of eggs and intake of vegetables+roots entered into the
model and were directly (positively) associated with plasma
total Q10 concentration (Table 2). The use of statins, the in-
tensity of conditioning exercise, intake of ¢sh and intake of
dairy products had an inverse association. With respect to the
most important determinants, serum cholesterol accounted for
20.1%, serum Q-GT for 12.0%, gender for 5.5% and serum
triglycerides for 3.1% of the variation of plasma Q10 concen-
tration. The variables shown in Table 2 in total accounted for
43.5% of the variation of plasma total Q10. Of the biochemical
measurements, hemoglobin was also entered into the model,
but was not included because of its strong positive correlation
with male gender. Even though self-reported alcohol con-
sumption and serum CDT were correlated, only alcohol in-
take was associated with plasma Q10 and therefore included in
the model.
Male and female subjects were also studied separately. In
men (n = 254), the strongest directly (positively) associated
determinants were serum cholesterol, serum Q-GT and serum
triglycerides accounting, respectively, for 18.4%, 14.7% and
3.4% of the variation of plasma Q10. In women (n = 264),
serum cholesterol, serum triglycerides and smoking were
also directly associated, accounting for 30.7%, 6.1% and
1.8% of the variation of plasma Q10, respectively.
On the basis of a separate covariance analysis, there was a
signi¢cant di¡erence in plasma Q10 levels between genders
after adjusting for all of the factors that entered into the
regression model (Table 2). In men, the adjusted plasma Q10
levels were 13.3% higher (P6 0.001) than in women
(1.11 þ 0.29 Wmol/l vs. 0.98 þ 0.25 Wmol/l, mean þ S.D.). Cor-
responding crude values were approximately the same as these
adjusted values.
In the present study, 12 subjects were undergoing regular
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Table 1
Characteristics of the main determinants of plasma coenzyme Q10 (n = 518)
Mean þ S.D. Minimum Maximum
Chemical measurements
Plasma Q10 (Wmol/l) 1.04 þ 0.28 0.28 2.31
Serum cholesterol (mmol/l) 6.41 þ 0.98 3.41 11.57
Serum Q-GT (U/l) 34 þ 41 1 666
Serum triglycerides (mmol/l) 1.60 þ 1.17 0.38 21.60
Anthropometric characteristics
Gender (0 = female vs. 1 = male) 0.49 þ 0.50 0 1
Age (years) 59.9 þ 5.6 45.4 70.4
Behavioral factors
Alcohol consumption (g/day) 3.6 þ 9.3 0.0 122.0
Mean weekly alcohol consumption (g/week) 61.6 þ 96.0 0.0 1117.4
Intensity of conditioning activity (mean METs) 5.57 þ 1.33 3.00 11.57
Use of statins (0 = non-user vs. 1 = user) 0.02 þ 0.15 0 1
Body mass index (kg/m2) 26.1 þ 3.1 17.3 33.1
Smoking (0 = no vs. 1 = yes) 0.47 þ 0.50 0 1
Dietary nutrients
Fish (g/day) 42.3 þ 50.2 0.0 346.6
Dairy products (g/day) 484.6 þ 270.3 15.0 1781.2
Vegetables+roots (g/day) 289.4 þ 129.5 16.3 716.9
Eggs (g/day) 24.8 þ 20.2 0.0 127.8
Table 2








Serum cholesterol (mmol/l) 0.421 122.2 101.6, 142.8 6 0.0001
Serum Q-GT (U/l) 0.250 1.71 1.24, 2.18 6 0.0001
Serum triglycerides (mmol/l) 0.189 45.79 28.60, 62.97 6 0.0001
Anthropometric characteristics
Gender (0 = female vs. 1 = male) 0.239 135.1 94.8, 175.3 6 0.0001
Age (years) 0.083 4.22 0.75, 7.68 0.017
Behavioral factors
Alcohol consumption (g/day) 0.079 2.40 0.29, 4.51 0.026
Intensity of conditioning activity (mean METs) 30.075 316.1 330.9, 31.3 0.033
Use of statins (0 = no vs. 1 = yes) 30.068 3127.3 3252.6, 31.9 0.047
Body mass index (kg/m2) 0.055 5.08 31.10, 11.25 0.107
Smoking (0 = no vs. 1 = yes) 0.052 29.58 310.96, 70.12 0.152
Dietary nutrients
Fish (g/day) 30.087 30.49 30.88, 30.11 0.012
Dairy products (g/day) 30.077 30.08 30.15, 30.01 0.024
Vegetables+roots (g/day) 0.063 0.14 30.01, 0.29 0.071
Eggs (g/day) 0.052 0.73 30.21, 1.67 0.130
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statin treatment. After adjusting for the strongest determi-
nants of plasma Q10 (presented in Table 2), the plasma Q10
levels were 13.1% lower in statin users (P = 0.047) compared
to non-users (0.86 þ 0.27 Wmol/l vs. 0.99 þ 0.28 Wmol/l). The
corresponding crude values were 22.9% lower in statin users
(0.81 þ 0.27 Wmol/l vs. 1.05 þ 0.28 Wmol/l).
We also assessed if there was a trend between weekly use of
alcohol and crude mean plasma Q10 levels (in quarters) (Fig.
1). The mean weekly use of alcohol was signi¢cantly higher in
men than in women (98.1 þ 121.1 vs. 26.5 þ 38.9 g/week). In
men, there was also a signi¢cant positive trend across quarters
(P = 0.002 for linearity).
Crude mean plasma Q10 levels are presented in Fig. 2 in
four age groups (6 55, 55^59, 60^64 and 65^70 years). In
women, there was a positive trend between age groups and
unadjusted plasma Q10 values (P = 0.016 for linearity).
4. Discussion
The present study is the ¢rst population study assessing
both endogenous and exogenous determinants of the plasma
Q10 concentration in humans. Some determinants of plasma
Q10 have already been studied [8,10]. However, in previous
studies, the numbers of subjects were small. The purpose of
the present study was, ¢rstly, to con¢rm the earlier ¢ndings at
a population level and secondly, to identify new factors which
could determine plasma Q10. There are some previous studies
suggesting that plasma Q10 would be of clinical signi¢cance.
Low plasma Q10 levels have been associated with major dis-
eases, such as coronary artery disease [4]. However, the results
presented have not been su⁄ciently reliable due to the fact
that determinants of plasma Q10 are only partly known.
In the present study, serum cholesterol, serum Q-GT, gender
and serum triglycerides were found to be the strongest deter-
minants of plasma Q10. The association between serum cho-
lesterol or triglycerides and plasma Q10 levels is understand-
able, since serum lipoproteins (which consist of cholesterol
and triglycerides) are carriers of Q10 in the circulation. Fur-
thermore, Q10 and cholesterol have partly a common synthesis
pathway [17]. Serum Q-GT is a marker of liver damage and
has been established to be a non-speci¢c indicator of alcohol
consumption. In addition to serum Q-GT, self-reported alco-
hol consumption was associated signi¢cantly with plasma Q10
levels. Liver damage, due to excess alcohol use or for any
other reason, could conceivably increase plasma Q10 levels
by releasing Q10 into the circulation. There is an alternative
mechanism, since alcohol has been established to non-specif-
ically stimulate metabolism in the liver, and in this way it also
might accelerate the hepatic synthesis of Q10. However, serum
CDT, which is thought to be a speci¢c indicator of excess
alcohol use, was not associated with plasma Q10 levels in
our study.
Many studies have shown that regular moderate alcohol
consumption is associated with a decreased severity of athero-
sclerosis and a reduced risk of cardiovascular events [18].
Thus, low plasma Q10 levels in patients with severe diseases
such as coronary artery disease could be attributable to lower
alcohol intake among these cases than the controls.
The plasma Q10 concentration was signi¢cantly higher in
men than in women. Adjustment for other determinants did
not change this ¢nding. It has been suggested that after 20
years of age, the total amount of Q10 in the human body
decreases with age [19]. In the present study, age had a sig-
ni¢cant direct association with plasma Q10, even after adjust-
ing for other determinants. A similar association has also been
found previously in the blood Q10 levels in a smaller study
[20]. Furthermore, in the present study, the intensity of con-
ditioning activity had a signi¢cant inverse association with
plasma Q10. There have also been previous ¢ndings indicating
that exercise can decrease blood Q10 levels [21]. These ¢ndings
suggest that plasma Q10 levels, at least to some degree, re£ect
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Fig. 1. Mean plasma Q10 levels in quarters of mean weekly alcohol
consumption (g/week). In women, the cut-o¡ values for quarters
were 1.2, 9.4 and 34.2 g of alcohol per week. In men, the cut-o¡
values were 20.8, 58.9 and 123.3 g of alcohol per week.
Fig. 2. Mean plasma Q10 levels in four age groups in men and
women. Numbers of subjects were: 6 55 years, 42 men and 54
women; 55^59 years, 74 men and 75 women; 60^64 years, 90 men
and 80 women and 65^70 years, 48 men and 55 women.
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the need for Q10 of the muscles and other organs rather than
their corresponding Q10 concentrations.
Meat and to a lesser extent ¢sh and vegetables, such as
broccoli and cauli£ower, have been suggested to be the
main dietary sources of Q10 [12,13]. In our present study,
dietary factors did not signi¢cantly a¡ect plasma Q10 levels,
even though eggs and vegetables+roots entered into the mod-
el. Fish and dairy products had an inverse association. In
men, the use of meat was signi¢cantly higher than in women.
For this reason, an adjustment for gender excluded meat from
the model. However, meat did not enter into the model when
male and female subjects were assessed separately. Further-
more, consumption of oils did not enter into these models.
These ¢ndings suggest that dietary intake of Q10 has only a
marginal e¡ect on plasma Q10 levels.
There is no agreement on the actual e¡ects of statins on
plasma Q10. In many studies where statins have decreased
plasma Q10 levels, it has often been proposed that this was
due to attenuated Q10 synthesis [17,22]. However, in these
studies, the reduction in plasma Q10 concentration during sta-
tin treatment could simply be a consequence of the reduction
in plasma cholesterol (lipoprotein) levels [23], which are the
carriers of Q10 in the circulation. Our present ¢nding was that
even after adjusting for the strongest determinants of plasma
Q10, including serum cholesterol, statin use was still associated
with reduced plasma Q10 levels, compared to levels in non-
statin users. However, though this association was signi¢cant,
only 12 subjects were receiving statin treatment in the present
study.
In conclusion, in addition to cholesterol and triglycerides,
there are several other factors, such as gender, alcohol con-
sumption (serum Q-GT), age, intensity of conditioning exer-
cise, and use of statins, which should be taken into account
when associations between plasma Q10 levels and di¡erent
diseases are studied. It is possible that these factors could
explain some or all of the reported associations between low
plasma/serum Q10 levels and diseases.
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